Diagnostic Accuracy of Procalcitonin, Neutrophil-to-Lymphocyte Ratio, and C-Reactive Protein in Detection of Bacterial Infections and Prediction of Outcome in Nonneutropenic Febrile Patients with Lung Malignancy

Table 5

The treatment and clinical response in bacteria-infected subgroup A and TF subgroup A.

	Response to therapy				Total
	PD	SD	PR	unknown
Bacteria-infected subgroup A (N = 69)
Treatment
Radiotherapy	13	11	1	5	30
Chemotherapy	3	12	0	0	15
Surgery					19
Others^a					5
TF subgroup A (N = 56)
Treatment
Radiotherapy	2	13	4	8	27
Chemotherapy	0	10	3	8	21
Surgery					1
Others^a					7

^aRefer mainly to targeted combination, conservative treatment, or suspension therapy. TF: tumor fever; PD: progressive disease; SD: stable disease; PR: partial response.